Our findings revealed that silencing the NCAPH gene effectively suppressed proliferation, reduced cell cycle progression in prostate cancer cells by directly inhibiting the PI3K/AKT/mTOR pathway, and decreased the expression of the transcription factor E2F1. This evidence concerns the gene E2F1 and prostate cancer.